Zeller named director of KL2 Scholars Program
Margaret “Meg” Zeller, PhD, professor in the Department of Pediatrics at the University of Cincinnati College of Medicine, has been named principal investigator and director of the UC KL2 Scholars Program, joining Jason Blackard, PhD, professor in the Department of Internal Medicine, Division of Digestive Diseases, who is co-director, in leading the program.
The KL2 Scholars Program is an institutional career development core of the Center for Clinical and Translational Science and Training (CCTST). A $4.1 million, five-year award received in 2020 provides funding for KL2 Research Scholars Mentored Career Development Awards.
Zeller replaces Jessica Kahn, MD, professor and Rauh Chair, director of adolescent and transition medicine and associate chair of academic affairs and career development in the Department of Pediatrics, who is now multiple principal investigator of the CCTST with Jareen Meinzen-Derr, PhD, professor in the Department of Pediatrics, and Brett Kissela, MD, executive vice dean and Albert Barnes Voorheis Professor of Neurology, Department of Neurology and Rehabilitation Medicine.
Meg Zeller, PhD (Photo courtesy of Cincinnati Children's)
Zeller joined the faculty in the Division of Behavioral Medicine and Clinical Psychology in 1999, with team science, mentorship and training program development and administration the central focus of her career. Her program of patient-oriented research focuses on pediatric obesity, with continuous funding as a National Institutes of Health principal investigator for more than 20 years. Additionally, she is the co-PI and co-director of Research Training in Child Behavior and Nutrition (T32DK06392-19). In assuming this new KL2 role, she will be stepping down as director of Psychology Fellowship Training at Cincinnati Children’s, a role she has held since 2012.
The objective of the KL2 Scholars Program is to successfully train diverse, multidisciplinary junior faculty members to conduct innovative, team-based, community-engaged clinical and translational research; develop sustainable careers in clinical and translational research; and disseminate and implement research findings that improve health outcomes and reduce disparities.
Featured photo at top of CARE/Crawley building. Photo/University of Cincinnati.
Tags
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.